Stabilized polymeric thiol reagents
AssigneeNektar Therapeutics
InventorsAntoni Kozlowski, Samuel McManus
Life of this patent
Estimating the term…
Abstract
Disclosed are water soluble polymeric reagents comprising the structure POLY-[Y—S—W]x, where POLY is a water soluble polymer; Y is a hydrocarbon-based spacer group, x is 1 to 25, and S—W is a thiol, protected thiol, or thiol-reactive derivative. Preferably, the water soluble polymer is a PEG polymer. Also disclosed are conjugates of such polymeric reagents with pharmaceutically relevant molecules, and methods of their formation and use.
Claims92
A water-soluble polymeric reagent comprising the structure:
- POLY-[Y—S—W]x
- wherein:
- POLY is a water soluble polymer;
- Y is a divalent linking group, containing at least four carbon atoms, and consisting of a saturated or unsaturated hydrocarbon backbone which is three to eight carbon atoms in length and has substituents which are independently selected from hydrogen, lower alkyl, lower alkenyl, and non-interfering substituents, where two such alkyl and/or alkenyl substituents on different carbon atoms of the backbone may be linked so as to form a cycloalkyl, cycloalkenyl,
- or aryl group;
- S is a sulfur atom attached to an sp3 hybridized carbon of Y;
- S—W is a thiol, protected thiol, or thiol-reactive thiol derivative;
- x=1-25;
- and
- POLY has a molecular weight of at least 500 when POLY is a linear polyethylene glycol, x=1, and Y is a linear alkyl chain.
A water-soluble polymeric reagent comprising the structure:
- PEG-[Y—S—W]x
- wherein:
- Y is a divalent linking group consisting of a saturated or unsaturated hydrocarbon backbone which is three to eight carbon atoms in length and has substituents which are independently selected from hydrogen, lower alkyl, lower alkenyl, and non-interfering substituents as defined herein, where two such alkyl and/or alkenyl substituents on different carbon atoms of the backbone may be linked so as to form a cycloalkyl, cycloalkenyl, or aryl group;
- S is a sulfur atom attached to an sp3 hybridized carbon of Y;
- S—W is a thiol, protected thiol, or thiol-reactive thiol derivative;
- x=1-25;
- and
- PEG has a molecular weight of at least 500 when PEG is linear, x=1, and Y is a linear alkyl chain.
A water-soluble polymeric reagent comprising the structure:
- POLY-[Y—S—W]x
- wherein:
- POLY is a water soluble polymer;
- Y is a divalent linking group, containing at least four carbon atoms, consisting of a saturated or unsaturated hydrocarbon backbone which is three to ten carbon atoms in length and has substituents which are independently selected from hydrogen, lower alkyl, lower alkenyl, and non-interfering substituents, where two such alkyl and/or alkenyl substituents on different carbon atoms of the backbone may be linked so as to form a cycloalkyl, cycloalkenyl, or aryl group;
- S is a sulfur atom attached to an sp3 hybridized carbon of Y;
- x is 2-25;
- and
- S—W is a thiol, protected thiol, or thiol-reactive thiol derivative.
A water-soluble polymeric reagent comprising the structure:
- PEG-[Y—S—W]x
- wherein:
- Y is a divalent linking group consisting of a saturated or unsaturated hydrocarbon backbone which is three to ten carbon atoms in length and has substituents which are independently selected from hydrogen, lower alkyl, lower alkenyl, and non-interfering substituents as defined herein, where two such alkyl and/or alkenyl substituents on different carbon atoms of the backbone may be linked so as to form a cycloalkyl, cycloalkenyl, or aryl group;
- S is a sulfur atom attached to an sp3 hybridized carbon of Y;
- x is 2-25;
- and
- S—W is a thiol, protected thiol, or thiol-reactive thiol derivative.
A polymer conjugate comprising the structure:
- POLY-[Y—S—S-A]x
- wherein:
- POLY is a water soluble polymer;
- Y is a linking group having a saturated or unsaturated hydrocarbon backbone which is three to ten carbon atoms in length and has substituents which are independently selected from hydrogen, lower alkyl, lower alkenyl, and non-interfering substituents as defined herein, where two such alkyl and/or alkenyl substituents on different carbon atoms of the backbone may be linked so as to form a cycloalkyl, cycloalkenyl, or aryl group;
- S—S is a disulfide group attached to an sp3 hybridized carbon of Y;
- and
- A is a covalently linked residue of a pharmacologically active molecule;
- and
- x is 1-25.
A polymer conjugate comprising the structure:
- POLYA-L—S—S—Y-POLYB-Y—S—S-A
- wherein:
- each of POLYA and POLYB is a water soluble polymer segment, where POLYB has a molecular weight of 10 KDa or less, and the sum of the molecular weights of POLYA and POLYB is at least 3 KDa;
- each Y is independently a divalent linking group consisting of a saturated or unsaturated hydrocarbon backbone which is three to ten carbon atoms in length and has substituents which are independently selected from hydrogen, lower alkyl, lower alkenyl, and non-interfering substituents as defined herein, where two such alkyl and/or alkenyl substituents on different carbon atoms of the backbone may be linked so as to form a cycloalkyl, cycloalkenyl, or aryl group;
- L is a linker group;
- each S—S is a disulfide group attached to an sp3 hybridized carbon of the adjacent Y;
- and A is a covalently linked residue of a pharmacologically active molecule.
A method for delivering a pharmacologically active molecule to a subject, said method comprising administering to the subject, in a pharmaceutically acceptable carrier, a conjugate comprising the structure:
- POLY-[Y—S—S-A]x
- wherein:
- P1 POLY is a water soluble polymer;
- Y is a divalent linking group consisting of a saturated or unsaturated hydrocarbon backbone which is three to ten carbon atoms in length and has substituents which are independently selected from hydrogen, lower alkyl, lower alkenyl, and non-interfering substituents as defined herein, where two such alkyl and/or alkenyl substituents on different carbon atoms of the backbone may be linked so as to form a cycloalkyl, cycloalkenyl, or aryl group;
- S—S is a disulfide group attached to an sp3 hybridized carbon of Y;
- x is 1-25;
- and
- A is a covalently linked residue of said pharmacologically active molecule, wherein said molecule has a reactive thiol group in unconjugated form.
Dependencies are inferred from the claim text.